130 related articles for article (PubMed ID: 38367520)
1. Simultaneous quantification of four hormone therapy drugs by LC-MS/MS: Clinical applications in breast cancer patients.
Mansour B; Ngo C; Schlemmer D; Robidou P; Blondel J; Marin C; Noé G; Procureur A; Jamelot M; Gligorov J; Salem JE; Zahr N
J Pharm Biomed Anal; 2024 May; 242():116032. PubMed ID: 38367520
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study.
Beer B; Schubert B; Oberguggenberger A; Meraner V; Hubalek M; Oberacher H
Anal Bioanal Chem; 2010 Oct; 398(4):1791-800. PubMed ID: 20730580
[TBL] [Abstract][Full Text] [Related]
3. A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer.
Poetto AS; Posocco B; Gagno S; Orleni M; Zanchetta M; Iacuzzi V; Canil G; Buzzo M; Montico M; Guardascione M; Basile D; Pelizzari G; Alberti M; Gerratana L; Puglisi F; Toffoli G
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122985. PubMed ID: 34700133
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients.
Bertelsen BE; Viste K; Helland T; Hagland M; Søiland H; Geisler J; Lende TH; Lønning PE; Sagen JV; Mellgren G; Almås B
J Clin Endocrinol Metab; 2022 Apr; 107(5):1368-1374. PubMed ID: 34958096
[TBL] [Abstract][Full Text] [Related]
5. Development and clinical validation of a simple and fast UPLC-ESI-MS/MS method for simultaneous quantification of nine kinase inhibitors and two antiandrogen drugs in human plasma: Interest for their therapeutic drug monitoring.
Llopis B; Robidou P; Tissot N; Pinna B; Gougis P; Aubart FC; Campedel L; Abbar B; Weil DR; Uzunov M; Gligorov J; Salem JE; Funck-Brentano C; Zahr N
J Pharm Biomed Anal; 2021 Apr; 197():113968. PubMed ID: 33618135
[TBL] [Abstract][Full Text] [Related]
6. Simple and accurate quantitative analysis of cefiderocol and ceftobiprole in human plasma using liquid chromatography-isotope dilution tandem mass spectrometry: interest for their therapeutic drug monitoring and pharmacokinetic studies.
Llopis B; Bleibtreu A; Schlemmer D; Robidou P; Paccoud O; Tissot N; Noé G; Junot H; Luyt CÉ; Funck-Brentano C; Zahr N
Clin Chem Lab Med; 2021 Oct; 59(11):1800-1810. PubMed ID: 34243226
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous quantification of 19 analytes in breast milk by liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Monfort A; Jutras M; Martin B; Boucoiran I; Ferreira E; Leclair G
J Pharm Biomed Anal; 2021 Sep; 204():114236. PubMed ID: 34273657
[TBL] [Abstract][Full Text] [Related]
8. Identification of the aromatase inhibitors anastrozole and exemestane in human urine using liquid chromatography/tandem mass spectrometry.
Mareck U; Geyer H; Guddat S; Haenelt N; Koch A; Kohler M; Opfermann G; Thevis M; Schänzer W
Rapid Commun Mass Spectrom; 2006; 20(12):1954-62. PubMed ID: 16715475
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a sensitive liquid chromatography/tandem mass spectrometry method for the determination of exemestane in human plasma.
Ksycińska H; Buś-Kwaśnik K; Szlagowska A; Rudzki PJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1905-10. PubMed ID: 21641878
[TBL] [Abstract][Full Text] [Related]
10. Establishment of an analytical method for simultaneous quantitation of CDK4/6 inhibitors, aromatase inhibitors, and an estrogen receptor antagonist in human plasma using LC-ESI-MS/MS.
Sato Y; Shigeta K; Hirasawa T; Sato T; Ogura J; Maekawa M; Ebata A; Hamanaka Y; Tada H; Ishida T; Kikuchi M; Mano N
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Mar; 1173():122655. PubMed ID: 33831689
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous quantitative analysis of letrozole, its carbinol metabolite, and carbinol glucuronide in human plasma by LC-MS/MS.
Precht JC; Ganchev B; Heinkele G; Brauch H; Schwab M; Mürdter TE
Anal Bioanal Chem; 2012 Apr; 403(1):301-8. PubMed ID: 22367241
[TBL] [Abstract][Full Text] [Related]
12. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
Zhang M; Liu X; Chen Z; Jiang S; Wang L; Tao M; Miao L
J Pharm Biomed Anal; 2022 Mar; 211():114562. PubMed ID: 35124453
[TBL] [Abstract][Full Text] [Related]
13. Dispersive liquid-liquid microextraction followed by sweeping micellar electrokinetic chromatography-tandem mass spectrometry for determination of six breast cancer drugs in human plasma.
Mlinarić Z; Turković L; Sertić M
J Chromatogr A; 2024 Mar; 1718():464698. PubMed ID: 38354504
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a rapid LC-MS/MS method to quantify letrozole in human plasma and its application to therapeutic drug monitoring.
Shao R; Yu LY; Lou HG; Ruan ZR; Jiang B; Chen JL
Biomed Chromatogr; 2016 Apr; 30(4):632-7. PubMed ID: 26317321
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of an UPLC-MS/MS method for the therapeutic drug monitoring of oral anti-hormonal drugs in oncology.
van Nuland M; Venekamp N; de Vries N; de Jong KAM; Rosing H; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Feb; 1106-1107():26-34. PubMed ID: 30639947
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a novel orally active SERD AZD9496 against hormone dependent post-menopausal breast cancer depends on inhibition of cellular aromatase activity.
Kazi A; Goloubeva O; Schech A; Yu S; Sabnis GJ
J Steroid Biochem Mol Biol; 2020 Sep; 202():105697. PubMed ID: 32461092
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of LC-MS/MS methods for the quantification of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, and its main metabolite M6 in human plasma, urine and feces: Application to a clinical study in healthy Chinese subjects.
Gao H; Cheng M; Liu H; Ding L
J Pharm Biomed Anal; 2023 Sep; 233():115498. PubMed ID: 37285657
[TBL] [Abstract][Full Text] [Related]
19. Quantification of the aromatase inhibitor letrozole and its carbinol metabolite in mouse plasma by UHPLC-MS/MS.
Taheri H; Jin Y; Ahmed E; Hu P; Li Y; Sparreboom A; Hu S
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 May; 1238():124106. PubMed ID: 38636136
[TBL] [Abstract][Full Text] [Related]
20. Validation of an LC-MS/MS assay for rapid and simultaneous quantification of 21 kinase inhibitors in human plasma and serum for therapeutic drug monitoring.
Al Shirity ZN; Westra N; Hateren KV; Munnink THO; Kosterink JGW; Mian P; Hooge MNL; Touw DJ; Gareb B
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Sep; 1229():123872. PubMed ID: 37716342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
